低氧酸盐在成年人中麻醉症和异常性高睡眠症的剂量优化:共识建议
Anne Marie Morse1, Richard K Bogan2, Asim Roy3
1Janet Weis Children's Hospital, Geisinger Medical Center, 100 North Academy Avenue, Danville, PA, 17822, USA. amorse@geisinger.edu.
Neurology and therapy
|April 25, 2024
概括
这项研究提供了有关启动低氧酸盐 (LXB) 治疗麻醉症和异常性高睡眠症的专家共识. 它提供了关于剂量,管理挑战和从氧酸盐过渡到LXB的指导,以改善患者的治疗结果.
科学领域:
- 睡眠医学 睡眠医学
- 药理学 药理学是指药理学的学科.
- 临床实践指南 临床实践指南
背景情况:
- 低氧酸盐 (LXB) 已被批准用于麻醉症和异常性高睡眠症.
- LXB为氧酸盐 (SXB) 提供了较低的替代品.
- 启动LXB需要指导,特别是在异常性高睡眠症和从SXB过渡时.
研究的目的:
- 为启动和优化低氧酸盐 (LXB) 治疗制定基于共识的建议.
- 提供关于剂量,管理挑战和从氧酸盐 (SXB) 过渡到LXB的指导.
- 支持临床医生有效使用LXB治疗麻醉症和异常性高睡眠症.
主要方法:
- 使用了经过修改的Delphi过程.
- 一个由五位睡眠专家组成的专家小组召开了会议,以达成共识.
- 为了就建议达成一致,举行了两次虚拟会议.
主要成果:
- 31个建议得到了高度共识的同意.
- 该指南涵盖了引入LXB,开始治疗麻醉症/异常性高睡眠症,应对挑战,以及从SXB过渡.
- 建议包括剂量策略,调节方案,管理不良事件和设定患者期望.
结论:
- 该资源为临床医生提供了针对优化LXB剂量的指导.
- 专家的共识支持在临床实践中安全有效地使用LXB.
- 这些建议旨在改善麻醉症和异常性高睡眠症患者的治疗结果.
相关概念视频
Management of Insomnia
244
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
244
Sedatives and Hypnotics Drugs: Miscellaneous Agents
171
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
171
Narcolepsy
101
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
101
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
131
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
131
Rational Dosage Regimen: Maintenance Dose and Loading Dose
4.0K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
4.0K
CNS Depressants: Barbiturates and Benzodiazepines
257
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
257


